Carlos Williams
Naval Medical Research Center
3 Papers
Carlos Williams is an academic researcher from Naval Medical Research Center. The author has contributed to research in topics: Medicine & Immunogenicity. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.
Mark S. Riddle,Robert W. Kaminski,Carlos Williams,Chad K. Porter,Shahida Baqar,Alexis A. Kordis,Theron C. Gilliland,Joyce Lapa,Melissa L. Coughlin,Chris Soltis,Erica Jones,Jackie Saunders,Paul B. Keiser,Paul B. Keiser,Ryan T. Ranallo,Robert Gormley,M.R. Nelson,K. Ross Turbyfill,David R. Tribble,Edwin V. Oaks +19 more
TL;DR: In this trial the S. flexneri 2a Invaplex 50 vaccine was safe, well-tolerated and induced robust levels of antigen-specific intestinal IgA and ASC responses and the spray device performed well and offered an advantage over pipette intranasal delivery.
71
Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
David R. Tribble,Robert W. Kaminski,Joyce A. Cantrell,M.R. Nelson,Chad K. Porter,Shahida Baqar,Carlos Williams,Rohit Arora,J. Saunders,M. Ananthakrishnan,John W. Sanders,G. Zaucha,R. Turbyfill,Edwin V. Oaks +13 more
TL;DR: The Invaplex 50 nasal vaccine was safe with encouraging mucosal immune responses and follow-on studies will optimize dose, delivery mechanism and assess efficacy in a S. flexneri 2a challenge study.
52
SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
Andrew G. Letizia,Irene Ramos,Ajay Obla,Carl Goforth,Dawn L. Weir,Yongchao Ge,Marcas M. Bamman,Jayeeta Dutta,Ethan Ellis,Luis A. Estrella,Mary-Catherine George,Ana S. Gonzalez-Reiche,William D. Graham,Adriana van de Guchte,Ramiro L. Gutierrez,Franca R. Jones,Aspasia Kalomoiri,Rhonda A. Lizewski,Stephen E. Lizewski,Jan Marayag,Nada Marjanovic,Eugene V. Millar,Venugopalan D. Nair,German Nudelman,Edgar Nunez,Brian L. Pike,Chad K. Porter,James Regeimbal,Stas Rirak,Ernesto Santa Ana,Rachel Sealfon,Robert Sebra,Mark P. Simons,Alessandra Soares-Schanoski,Victor A. Sugiharto,Michael Termini,Sindhu Vangeti,Carlos Williams,Olga G. Troyanskaya,Harm van Bakel,Stuart C. Sealfon +40 more
TL;DR: Among Marine Corps recruits, approximately 2% who had previously had negative results for SARS-CoV-2 at the beginning of supervised quarantine, and less than 2% of recruits with unknown previous status, tested positive by day 14.